POLXF — Polydex Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Polydex Pharmaceuticals, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

	2017 January 31st	2018 January 31st	2019 January 31st	2020 January 31st	2021 January 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1.27	1.28	1.59	0.523	1.64
Net Total Accounts Receivable
Net Total Receivables	1.1	1.55	1.01	1.33	1.03
Total Inventory
Prepaid Expenses
Total Current Assets	3.6	3.94	3.76	2.96	3.55
Net Property, Plant And Equipment	3.06	3.37	3.22	3.3	3.41
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	6.71	7.33	7.06	7.18	7.77
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.14	0.92	0.813	0.777	0.95
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	1.66	1.56	1.34	1.2	1.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5.04	5.77	5.72	5.98	6.47
Total Liabilities & Shareholders' Equity	6.71	7.33	7.06	7.18	7.77
Total Common Shares Outstanding
Total Preferred Shares Outstanding